Gilead Sciences (GILD) Misses Q4 EPS by 37c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ
6. MSFT
7. SPY
8. SKYD
9. IBM
10. CRWV

Go back to Gilead Sciences (GILD) Misses Q4 EPS by 37c, Offers Guidance

Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results

February 4, 2020 4:01 PM EST

- Fourth Quarter Product Sales of $5.8 billion -

- Full Year 2019 Product Sales of $22.1 billion -

- Full Year 2019 Diluted EPS of $4.22 per share -

- Full Year 2019 Non-GAAP Diluted EPS of $6.63 per share -

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2019. Total revenues for the fourth quarter of 2019 were $5.9 billion compared to... More